Background Malaria is a major cause of morbidity and mortality in pediatrics in malaria
endemic areas. Artemisinin-based combination therapies (ACTs) are the drugs of choice for …

Paediatric formulations of artemisinin combination therapies (ACTs) have recently been
developed for the treatment of children with falciparum malaria. Compared with conventional …

Background Artemisinin-based combination therapies (ACTs) are the mainstay for the
management of uncomplicated malaria cases. However, up-to-date data able to assist sub …

Background Management of uncomplicated Plasmodium falciparum malaria relies on
artemisinin-based combination therapies (ACTs). These highly effective regimens have …

Background Artemisinin-based combination therapy (ACT) and novel drug combinations are
available and used in African countries to treat uncomplicated malaria. Network meta …

Background Artemisinin-based combination therapy (ACT) and novel drug combinations are
available and used in African countries to treat uncomplicated malaria. Network meta …

ACTs are an essential tool in the fight to control and eliminate malaria. They are currently the
most effective drugs against P. falciparum malaria. They should be deployed through …

Background Artemisinin combination therapies (ACTs) are currently the preferred option for
treating uncomplicated malaria. Dihydroartemisinin-piperaquine (DHA-PQP) is a promising …

Introduction Artemisinin-based combination therapies (ACTs) are the first-line antimalarial
drugs used to treat uncomplicated Plasmodium falciparum alaria in many endemic countries …

An open-label, randomized controlled trial was carried out in 2011–2012 in the Democratic
Republic of the Congo to test the efficacy, safety, and tolerability of the artemisinin-based …